Cardlytics, Inc. (CDLX) Institutional Ownership

Ownership Summary

Cardlytics, Inc. (NASDAQ:CDLX) showed up in the 13F filings of 69 institutional investors as of December 2025.

• These investors held 32.6% of outstanding shares in December 2025, down from 45.6% in September 2025.
• They decreased total shares held in Cardlytics by -6.49% from last quarter, and the number of investors in CDLX decreased 37.84% annually.
• During the quarter, 27 of these 69 funds increased positions in CDLX, 25 reduced exposure, and 17 held steady.
• In total, institutional investors held 17.43Mn shares in Cardlytics as of December 2025, down by 1.21Mn shares quarter on quarter, and down 13.73Mn shares year over year.
• CAS Investment Partners, LLC holds the largest position in CDLX at 519.81K shares as of December 31, 2025, or 0.97% of shares outstanding.
• The most significant purchases of CDLX for the quarter ending December 2025 came from CAS Investment Partners, LLC (519.81K), VANGUARD CAPITAL MANAGEMENT LLC (206.34K), VANGUARD FIDUCIARY TRUST CO (32.47K), VANGUARD PORTFOLIO MANAGEMENT LLC (17.22K), HRT FINANCIAL LP (14.64K).
• The largest sellers of Cardlytics for the quarter ending December 2025 were Bank Of America Corp /De/ (142.46K), JACOBS LEVY EQUITY MANAGEMENT, INC (58.55K), GSA CAPITAL PARTNERS LLP (20.7K), MILLENNIUM MANAGEMENT LLC (18.92K), Goldman Sachs Group Inc (15.63K).
• Business Quant data shows the 10 biggest positions in Cardlytics as of December 2025 are held by CAS Investment Partners, LLC (519.81K), VANGUARD CAPITAL MANAGEMENT LLC (206.34K), RBF Capital, LLC (160.02K), 683 Capital Management, LLC (145.0K), KPS Global Asset Management UK Ltd (121.88K), WORLDLY PARTNERS MANAGEMENT, LLC (115.8K), BlackRock, Inc. (99.06K), GEODE CAPITAL MANAGEMENT, LLC (73.42K), Quinn Opportunity Partners LLC (46.24K), LPL Financial LLC (43.74K).